Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HIV-1/2 kits criticised in Danish study

This article was originally published in Clinica

Executive Summary

Some of the most sensitive combined HIV screening assays can miss HIV-2 until 10 weeks after infection, according to a Danish study. The most sensitive tests can be strongly positive as early as 37 days. Last year manufacturers upgraded the sensitivity of their kits to detect subtype-O. It may now be time to do the same for HIV-2, says Dr Claus Bohn Christiansen and a team at the State Serum and Vaccine Institute in Copenhagen.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT088467

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel